Patients with atrial fibrillation (AF) who use a direct oral anticoagulant (DOAC) dose that’s inconsistent with US Food and Drug Administration labeling—a practice believed, in many cases, to be ...
Among patients hospitalized for atrial fibrillation (AF) or flutter, prescription of an off-label dose of a direct oral anticoagulant (DOAC) at discharge remains relatively common, according to data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback